Diabetic retinopathy (DR) is a leading cause of vision-loss globally. Of an estimated 285
million people with diabetes mellitus worldwide, approximately one third have signs of DR …

The number of patients with type 2 diabetes is increasing rapidly in both developed and
developing countries around the world. The emerging pandemic is driven by the combined …

Deep learning (DL) has revolutionized the field of computer vision and image processing. In
medical imaging, algorithmic solutions based on DL have been shown to achieve high …

To examine the prevalence and incidence of diabetic eye disease (DED) among individuals
with diabetes in Europe, a systematic review to identify all published European prevalence …

Diabetes reduces life expectancy by five to 10 years. Premature cardiovascular disease is
the most common cause of morbidity and mortality, but the microvascular complications …

Diabet. Med. 27, 249–256 (2010) Abstract This paper systematically reviews the published
literature on the economic evidence of diabetic retinopathy screening. Twenty‐nine …

Purpose: Diabetes is a major public health problem affecting 415 million people worldwide.
With the increasing prevalence of diabetes, diabetic retinopathy (DR) is emerging as the …

Deep learning-based systems can achieve a diagnostic performance comparable to
physicians in a variety of medical use cases including the diagnosis of diabetic retinopathy …

Abstract Aims A National Screening Programme for diabetic eye disease in the UK is in
development. We propose a grading and early disease management protocol to detect sight …

Objectives To determine the incidence of any and referable diabetic retinopathy in people
with type 2 diabetes mellitus attending an annual screening service for retinopathy and …